167 related articles for article (PubMed ID: 34720041)
1. Hypertrophic cardiomyopathy or athlete's heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters.
Bakogiannis C; Mouselimis D; Tsarouchas A; Papatheodorou E; Vassilikos VP; Androulakis E
Eur J Sport Sci; 2023 Jan; 23(1):143-154. PubMed ID: 34720041
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM.
Gastl M; Lachmann V; Christidi A; Janzarik N; Veulemans V; Haberkorn S; Holzbach L; Jacoby C; Schnackenburg B; Berrisch-Rahmel S; Zeus T; Kelm M; Bönner F
Eur Radiol; 2021 May; 31(5):2768-2777. PubMed ID: 33063183
[TBL] [Abstract][Full Text] [Related]
3. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging.
Galderisi M; Cardim N; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Edvardsen T; Freitas A; Habib G; Kitsiou A; Plein S; Petersen SE; Popescu BA; Schroeder S; Burgstahler C; Lancellotti P
Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):353. PubMed ID: 25681828
[TBL] [Abstract][Full Text] [Related]
4. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.
Kübler J; Burgstahler C; Brendel JM; Gassenmaier S; Hagen F; Klingel K; Olthof SC; Blume K; Wolfarth B; Mueller KAL; Greulich S; Krumm P
Int J Cardiovasc Imaging; 2021 Aug; 37(8):2501-2515. PubMed ID: 34019206
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
Vilades D; Garcia-Moll X; Gomez-Llorente M; Pujadas S; Ferrero-Gregori A; Doñate T; Mirabet S; Leta R; Pons-Lladó G; Carreras F; Cinca J
Int J Cardiol; 2021 May; 330():232-237. PubMed ID: 33621621
[TBL] [Abstract][Full Text] [Related]
6. Insight Into Myocardial Microstructure of Athletes and Hypertrophic Cardiomyopathy Patients Using Diffusion Tensor Imaging.
Das A; Chowdhary A; Kelly C; Teh I; Stoeck CT; Kozerke S; Maxwell N; Craven TP; Jex NJ; Saunderson CED; Brown LAE; Ben-Arzi H; Sengupta A; Page SP; Swoboda PP; Greenwood JP; Schneider JE; Plein S; Dall'Armellina E
J Magn Reson Imaging; 2021 Jan; 53(1):73-82. PubMed ID: 32558016
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
[TBL] [Abstract][Full Text] [Related]
8. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
Czimbalmos C; Csecs I; Toth A; Kiss O; Suhai FI; Sydo N; Dohy Z; Apor A; Merkely B; Vago H
PLoS One; 2019; 14(2):e0211624. PubMed ID: 30763323
[TBL] [Abstract][Full Text] [Related]
9. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
[TBL] [Abstract][Full Text] [Related]
10. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
Wasfy MM; Weiner RB
Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
[TBL] [Abstract][Full Text] [Related]
13. Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart.
Calore C; Zorzi A; Corrado D
J Electrocardiol; 2015; 48(3):373-9. PubMed ID: 25595718
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Yield of Cardiac Magnetic Resonance in Athletes with and without Features of the Athlete's Heart and Suspected Structural Heart Disease.
Małek ŁA; Miłosz-Wieczorek B; Marczak M
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457693
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
Negri F; Muser D; Driussi M; Sanna GD; Masè M; Cittar M; Poli S; De Bellis A; Fabris E; Puppato M; Grigoratos C; Todiere G; Aquaro GD; Sinagra G; Imazio M
Int J Cardiol; 2021 Dec; 345():61-67. PubMed ID: 34728259
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular dyssynchrony and 2D and 3D global longitudinal strain for differentiating physiological and pathological left ventricular hypertrophy.
Ternacle J; Bremont C; d'Humieres T; Faivre L; Doan HL; Gallet R; Oliver L; Dubois-Randé JL; Lim P
Arch Cardiovasc Dis; 2017; 110(6-7):403-412. PubMed ID: 28065448
[TBL] [Abstract][Full Text] [Related]
17. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy: a comparison of motion-compensated spin echo and stimulated echo techniques.
Khalique Z; Scott AD; Ferreira PF; Nielles-Vallespin S; Firmin DN; Pennell DJ
MAGMA; 2020 Jun; 33(3):331-342. PubMed ID: 31758419
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
[TBL] [Abstract][Full Text] [Related]
20. Additional prognostic values of strain and strain rate over late gadolinium enhancement in hypertrophic cardiomyopathy patients.
Qin L; Zhu S; Liu P; Zhu L; Chen C; Gu S; Yang W; Zhou M; Yan F
Int J Cardiol; 2023 Jan; 370():427-434. PubMed ID: 36332750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
